Technical Analysis for NYR - Nyrada Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Fell Below 20 DMA | Bearish | 10.00% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 10.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 10.00% | |
Narrow Range Bar | Range Contraction | 10.00% | |
Wide Bands | Range Expansion | 10.00% | |
Down 3 Days in a Row | Weakness | 10.00% | |
Down 4 Days in a Row | Weakness | 10.00% | |
Wide Bands | Range Expansion | 3.13% |
Alert | Time |
---|---|
Up 10% | about 6 hours ago |
Non-ADX 1,2,3,4 Pullback Entry | about 6 hours ago |
1,2,3, Pullback Entry | about 6 hours ago |
Rose Above Previous Day's High | about 6 hours ago |
Outside Day | about 6 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Nyrada Inc (NYR) is a preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. It focuses on areas of substantial unmet clinical need and has identified drug candidates with therapeutic and commercial potential, where few if any, effective or well-tolerated therapies exist. It currently has three wholly-owned drug programs:
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Diseases Drugs Drug Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Diseases Drugs Drug Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.17 |
52 Week Low | 0.018 |
Average Volume | 5,516,780 |
200-Day Moving Average | 0.057 |
50-Day Moving Average | 0.054 |
20-Day Moving Average | 0.102 |
10-Day Moving Average | 0.104 |
Average True Range | 0.016 |
RSI (14) | 56.33 |
ADX | 50.54 |
+DI | 37.983 |
-DI | 17.956 |
Chandelier Exit (Long, 3 ATRs) | 0.123 |
Chandelier Exit (Short, 3 ATRs) | 0.066 |
Upper Bollinger Bands | 0.135 |
Lower Bollinger Band | 0.070 |
Percent B (%b) | 0.45 |
BandWidth | 63.148 |
MACD Line | 0.014 |
MACD Signal Line | 0.018 |
MACD Histogram | -0.0042 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.122 | ||||
Resistance 3 (R3) | 0.119 | 0.110 | 0.118 | ||
Resistance 2 (R2) | 0.110 | 0.104 | 0.111 | 0.116 | |
Resistance 1 (R1) | 0.104 | 0.100 | 0.107 | 0.107 | 0.115 |
Pivot Point | 0.095 | 0.095 | 0.096 | 0.096 | 0.095 |
Support 1 (S1) | 0.089 | 0.089 | 0.092 | 0.092 | 0.083 |
Support 2 (S2) | 0.080 | 0.085 | 0.081 | 0.082 | |
Support 3 (S3) | 0.074 | 0.080 | 0.080 | ||
Support 4 (S4) | 0.077 |